The impact of the human microbiome on health and disease is of utmost importance and has
been studied intensively in recent years. Microbes promote immune system development …

Chronic obstructive pulmonary disease (COPD) and lung cancer 17 are two of the most
prevalent and debilitating respiratory diseases worldwide, both associated with high …

Rationale: Progressive lung function loss is recognized in chronic obstructive pulmonary
disease (COPD); however, no study concurrently evaluates how accelerated lung function …

Pulmonary ionocytes express high levels of cystic fibrosis transmembrane conductance
regulator (CFTR), an anion channel that is critical for hydration of the airways and …

Introduction Numerous delivery strategies, primarily novel nucleic acid delivery carriers,
have been developed and explored to enable therapeutically relevant lung gene therapy …

Cystic fibrosis (CF) is a lifelong disorder affecting 1 in 3500 live births worldwide. It is a
monogenetic autosomal recessive disease caused by loss-of-function mutations in the gene …

Cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) are characterized by
increasingly frequent acute pulmonary exacerbations that reduce life quality and length …

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality
worldwide, particularly in low-and middle-income countries, where it poses a significant …

Chronic obstructive pulmonary disease (COPD) is a leading cause of death and cigarette
smoke is the main risk factor. Detecting its earliest stages and preventing a decline in lung …

Aquaporins (AQPs) are a subgroup of small transmembrane transporters that are distributed
in various types of tissues, including the lung, kidney, heart and central nervous system. It is …